AMY MILLER: Open Payments
NPI 1427039353 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 48 payments from 12 companies in 2025. Trend: 2023 $657 · 2024 $725 · 2025 $1,094
Food & beverage: $1,068Education: $25
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $381 |
| E.R. Squibb & Sons, L.L.C. | 6 | $159 |
| ABBVIE INC. | 5 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $101 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 3 | $43 |
| Lundbeck LLC | 2 | $42 |
| Alkermes, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $31 |
Products named: FANAPT, COBENFY, VRAYLAR, HETLIOZ, TRINTELLIX, REXULTI, UZEDY, Jornay PM.
Industry payments across WI — which companies pay providers there.
